;PMID: 3334851
;source_file_2884.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..48] = [t:0..48]
;1)sentence:[e:54..221] = [t:54..221]
;2)section:[e:225..302] = [t:225..302]
;3)section:[e:306..372] = [t:306..372]
;4)sentence:[e:376..605] = [t:376..605]
;5)sentence:[e:606..676] = [t:606..676]
;6)sentence:[e:677..916] = [t:677..916]
;7)sentence:[e:917..1029] = [t:917..1029]
;8)sentence:[e:1030..1189] = [t:1030..1189]
;9)sentence:[e:1190..1369] = [t:1190..1369]
;10)section:[e:1373..1417] = [t:1373..1417]

;section 0 Span:0..48
;Biochim Biophys Acta.  1988 Jan 25;949(1):58-64.
(SEC
  (FRAG (NNP:[0..7] Biochim) (NNP:[8..15] Biophys) (NNP:[16..20] Acta)
        (.:[20..21] .) (CD:[23..27] 1988) (NNP:[28..31] Jan)
        (CD:[32..39] 25;949-LRB-) (CD:[39..40] 1) (-RRB-:[40..41] -RRB-)
        (::[41..42] :) (CD:[42..47] 58-64) (.:[47..48] .)))

;sentence 1 Span:54..221
;Expression of transfected human CuZn superoxide dismutase gene in mouse L
;cells  and NS20Y neuroblastoma cells induces enhancement of glutathione
;peroxidase  activity.
;[86..111]:gene-rna:"CuZn superoxide dismutase"
;[145..158]:malignancy-type:"neuroblastoma"
;[188..210]:gene-protein:"glutathione peroxidase"
(SENT
  (S-HLN
    (NP-SBJ
      (NP (NN:[54..64] Expression))
      (PP (IN:[65..67] of)
        (NP (VBN:[68..79] transfected) (JJ:[80..85] human)
          (NML (NN:[86..90] CuZn) (NN:[91..101] superoxide)
               (NN:[102..111] dismutase))
          (NN:[112..116] gene)))
      (PP-LOC (IN:[117..119] in)
        (NP
          (NP (NN:[120..125] mouse) (NN:[126..127] L) (NNS:[128..133] cells))
          (CC:[135..138] and)
          (NP (NN:[139..144] NS20Y) (NN:[145..158] neuroblastoma)
              (NNS:[159..164] cells)))))
    (VP (VBZ:[165..172] induces)
      (NP
        (NP (NN:[173..184] enhancement))
        (PP (IN:[185..187] of)
          (NP
             (NN:[188..199] glutathione) (NN:[200..210] peroxidase)
            (NN:[212..220] activity)))))
    (.:[220..221] .)))

;section 2 Span:225..302
;Ceballos I, Delabar JM, Nicole A, Lynch RE, Hallewell RA, Kamoun P, Sinet
;PM.
(SEC
  (FRAG (NNP:[225..233] Ceballos) (NNP:[234..235] I) (,:[235..236] ,)
        (NNP:[237..244] Delabar) (NNP:[245..247] JM) (,:[247..248] ,)
        (NNP:[249..255] Nicole) (NNP:[256..257] A) (,:[257..258] ,)
        (NNP:[259..264] Lynch) (NNP:[265..267] RE) (,:[267..268] ,)
        (NNP:[269..278] Hallewell) (NNP:[279..281] RA) (,:[281..282] ,)
        (NNP:[283..289] Kamoun) (NNP:[290..292] P,) (NNP:[293..298] Sinet)
        (NNP:[299..301] PM) (.:[301..302] .)))

;section 3 Span:306..372
;Laboratoire de Biochimie Genetique, Hopital Necker, Paris, France.
(SEC
  (FRAG (NNP:[306..317] Laboratoire) (IN:[318..320] de)
        (NNP:[321..330] Biochimie) (NNP:[331..340] Genetique) (,:[340..341] ,)
        (NNP:[342..349] Hopital) (NNP:[350..356] Necker) (,:[356..357] ,)
        (NNP:[358..363] Paris) (,:[363..364] ,) (NNP:[365..371] France)
        (.:[371..372] .)))

;sentence 4 Span:376..605
;The human CuZn superoxide dismutase (superoxide dismutase 1) a key enzyme in
;the  metabolism of oxygen free-radicals, is encoded by a gene located on
;chromosome  21 in the region 21 q 22.1 known to be involved in Down's
;syndrome.
;[386..411]:gene-protein:"CuZn superoxide dismutase"
;[413..435]:gene-protein:"superoxide dismutase 1"
;[526..564]:variation-location:"chromosome  21 in the region 21 q 22.1"
(SENT
  (S
    (NP-SBJ-1
      (NP
        (NP (DT:[376..379] The) (JJ:[380..385] human)
           (NN:[386..390] CuZn) (NN:[391..401] superoxide)
           (NN:[402..411] dismutase))
        (NP (-LRB-:[412..413] -LRB-)
           (NN:[413..423] superoxide) (NN:[424..433] dismutase)
           (CD:[434..435] 1)
          (-RRB-:[435..436] -RRB-)))
      (NP
        (NP (DT:[437..438] a) (JJ:[439..442] key) (NN:[443..449] enzyme))
        (PP (IN:[450..452] in)
          (NP
            (NP (DT:[453..456] the) (NN:[458..468] metabolism))
            (PP (IN:[469..471] of)
              (NP (NN:[472..478] oxygen) (JJ:[479..483] free)
                  (HYPH:[483..484] -) (NNS:[484..492] radicals)))))))
    (,:[492..493] ,)
    (VP (VBZ:[494..496] is)
      (VP (VBN:[497..504] encoded)
        (NP-1 (-NONE-:[504..504] *))
        (PP (IN:[505..507] by)
          (NP
            (NP (DT:[508..509] a) (NN:[510..514] gene))
            (VP (VBN:[515..522] located)
              (NP (-NONE-:[522..522] *))
              (PP-LOC (IN:[523..525] on)
                (NP
                  (NP
                    (NP (NN:[526..536] chromosome) (CD:[538..540] 21))
                    (PP-LOC (IN:[541..543] in)
                      (NP
                        (NP (DT:[544..547] the) (NN:[548..554] region))
                        (NP (CD:[555..557] 21) (NN:[558..559] q)
                            (CD:[560..564] 22.1)))))
                  (VP (VBN:[565..570] known)
                    (S
                      (NP-SBJ-2 (-NONE-:[570..570] *))
                      (VP (TO:[571..573] to)
                        (VP (VB:[574..576] be)
                          (VP (VBN:[577..585] involved)
                            (NP-2 (-NONE-:[585..585] *))
                            (PP-CLR (IN:[586..588] in)
                              (NP
                                (NP (NNP:[589..593] Down) (POS:[593..595] 's))
                                (NN:[596..604] syndrome)))))))))))))))
    (.:[604..605] .)))

;sentence 5 Span:606..676
;A gene  dosage effect for this enzyme has been reported in trisomy 21.
;[665..672]:variation-type:"trisomy"
;[673..675]:variation-location:"21"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[606..607] A)
        (NML (NN:[608..612] gene) (NN:[614..620] dosage))
        (NN:[621..627] effect))
      (PP (IN:[628..631] for)
        (NP (DT:[632..636] this) (NN:[637..643] enzyme))))
    (VP (VBZ:[644..647] has)
      (VP (VBN:[648..652] been)
        (VP (VBN:[653..661] reported)
          (NP-1 (-NONE-:[661..661] *))
          (PP (IN:[662..664] in)
            (NP (NN:[665..672] trisomy) (CD:[673..675] 21))))))
    (.:[675..676] .)))

;sentence 6 Span:677..916
;To assess the  biological consequences of superoxide dismutase 1
;overproduction within cells,  the human superoxide dismutase 1 gene and a
;human superoxide dismutase 1 cDNA  were introduced into mouse L cells and
;NS20Y neuroblastoma cells.
;[719..741]:gene-protein:"superoxide dismutase 1"
;[782..804]:gene-rna:"superoxide dismutase 1"
;[822..844]:gene-rna:"superoxide dismutase 1"
;[896..909]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (S-PRP
      (NP-SBJ (-NONE-:[677..677] *))
      (VP (TO:[677..679] To)
        (VP (VB:[680..686] assess)
          (NP
            (NP (DT:[687..690] the) (JJ:[692..702] biological)
                (NNS:[703..715] consequences))
            (PP (IN:[716..718] of)
              (NP
                (NP
                  (NML (NN:[719..729] superoxide) (NN:[730..739] dismutase)
                       (CD:[740..741] 1))
                  (NN:[742..756] overproduction))
                (PP (IN:[757..763] within)
                  (NP (NNS:[764..769] cells)))))))))
    (,:[769..770] ,)
    (NP-SBJ-1
      (NP (DT:[772..775] the) (JJ:[776..781] human)
        (NML (NN:[782..792] superoxide) (NN:[793..802] dismutase)
             (CD:[803..804] 1))
        (NN:[805..809] gene))
      (CC:[810..813] and)
      (NP (DT:[814..815] a) (JJ:[816..821] human)
        (NML (NN:[822..832] superoxide) (NN:[833..842] dismutase)
             (CD:[843..844] 1))
        (NN:[845..849] cDNA)))
    (VP (VBD:[851..855] were)
      (VP (VBN:[856..866] introduced)
        (NP-1 (-NONE-:[866..866] *))
        (PP-DIR (IN:[867..871] into)
          (NP
            (NP (NN:[872..877] mouse) (NN:[878..879] L) (NNS:[880..885] cells))
            (CC:[886..889] and)
            (NP (NN:[890..895] NS20Y) (NN:[896..909] neuroblastoma)
                (NNS:[910..915] cells))))))
    (.:[915..916] .)))

;sentence 7 Span:917..1029
;Both cell  types expressed elevated levels (up to 3-fold) of enzymatically
;active human  superoxide dismutase 1.
;[1006..1028]:gene-protein:"superoxide dismutase 1"
(SENT
  (S
    (NP-SBJ (DT:[917..921] Both) (NN:[922..926] cell) (NNS:[928..933] types))
    (VP (VBD:[934..943] expressed)
      (NP
        (NP (VBN:[944..952] elevated) (NNS:[953..959] levels)
          (PRN (-LRB-:[960..961] -LRB-)
            (NP
              (QP (RB:[961..963] up) (TO:[964..966] to) (CD:[967..968] 3))
              (HYPH:[968..969] -) (JJ:[969..973] fold))
            (-RRB-:[973..974] -RRB-)))
        (PP (IN:[975..977] of)
          (NP
            (ADJP (RB:[978..991] enzymatically) (JJ:[992..998] active))
            (JJ:[999..1004] human)
             (NN:[1006..1016] superoxide) (NN:[1017..1026] dismutase)
             (CD:[1027..1028] 1)))))
    (.:[1028..1029] .)))

;sentence 8 Span:1030..1189
;These human superoxide dismutase 1 overproducers,  especially neuronal cell
;lines, showed an increased activity in the  selenodependent glutathione
;peroxidase.
;[1042..1064]:gene-protein:"superoxide dismutase 1"
;[1166..1188]:gene-protein:"glutathione peroxidase"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1030..1035] These) (JJ:[1036..1041] human)
        (NML (NN:[1042..1052] superoxide) (NN:[1053..1062] dismutase)
             (CD:[1063..1064] 1))
        (NNS:[1065..1078] overproducers))
      (,:[1078..1079] ,)
      (NP (RB:[1081..1091] especially) (JJ:[1092..1100] neuronal)
          (NN:[1101..1105] cell) (NNS:[1106..1111] lines)))
    (,:[1111..1112] ,)
    (VP (VBD:[1113..1119] showed)
      (NP (DT:[1120..1122] an) (VBN:[1123..1132] increased)
          (NN:[1133..1141] activity))
      (PP (IN:[1142..1144] in)
        (NP (DT:[1145..1148] the) (JJ:[1150..1165] selenodependent)
           (NN:[1166..1177] glutathione) (NN:[1178..1188] peroxidase))))
    (.:[1188..1189] .)))

;sentence 9 Span:1190..1369
;These data are consistent with the  possibility that gene dosage of
;superoxide dismutase 1 contributes to oxygen  metabolism modifications
;previously described in Down's syndrome.
;[1258..1280]:gene-generic:"superoxide dismutase 1"
(SENT
  (S
    (NP-SBJ (DT:[1190..1195] These) (NNS:[1196..1200] data))
    (VP (VBP:[1201..1204] are)
      (ADJP-PRD (JJ:[1205..1215] consistent)
        (PP (IN:[1216..1220] with)
          (NP
            (NP (DT:[1221..1224] the) (NN:[1226..1237] possibility))
            (SBAR (IN:[1238..1242] that)
              (S
                (NP-SBJ
                  (NP (NN:[1243..1247] gene) (NN:[1248..1254] dosage))
                  (PP (IN:[1255..1257] of)
                    (NP (NN:[1258..1268] superoxide) (NN:[1269..1278] dismutase)
                        (CD:[1279..1280] 1))))
                (VP (VBZ:[1281..1292] contributes)
                  (PP-CLR (TO:[1293..1295] to)
                    (NP
                      (NP (NN:[1296..1302] oxygen) (NN:[1304..1314] metabolism)
                          (NNS:[1315..1328] modifications))
                      (VP
                        (ADVP (RB:[1329..1339] previously))
                        (VBN:[1340..1349] described)
                        (NP (-NONE-:[1349..1349] *))
                        (PP (IN:[1350..1352] in)
                          (NP
                            (NP (NNP:[1353..1357] Down) (POS:[1357..1359] 's))
                            (NN:[1360..1368] syndrome)))))))))))))
    (.:[1368..1369] .)))

;section 10 Span:1373..1417
;PMID: 3334851 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1373..1377] PMID) (::[1377..1378] :) (CD:[1379..1386] 3334851)
        (NN:[1387..1388] -LSB-) (NNP:[1388..1394] PubMed) (::[1395..1396] -)
        (NN:[1397..1404] indexed) (IN:[1405..1408] for)
        (NNP:[1409..1417] MEDLINE-RSB-)))
